Gelmedix

Newton, United States

Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.

$13.0M raised

Feb 2026

Seed

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gelmedix

How much funding has Gelmedix raised?

Gelmedix has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in February 2026.

Where is Gelmedix headquartered?

Gelmedix is headquartered in Newton, United States.

What does Gelmedix do?

Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.

What stage is Gelmedix at?

Gelmedix is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 17, 2026.

MLA

"Gelmedix — Funding & Investors." VCBacked, February 17, 2026, https://www.vcbacked.co/company/gelmedix. Accessed June 3, 2026.

APA

VCBacked. (2026). Gelmedix — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/gelmedix

Wikipedia (cite web)

{{cite web |title=Gelmedix — Funding & Investors |url=https://www.vcbacked.co/company/gelmedix |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 17, 2026.